Rite Aid Q1 Sales Overview: Investments in Store Remodeling Are Starting to Payoff

Despite continued headwinds, the company exceeded its full year guidance, which it had raised after an impressive Q3. This outperformance was primarily driven by higher front-end and pharmacy sales. While a more severe flu season worked in favor of Rite Aid, it was partially offset by the launch of new generics (which being cheaper lowered the price per prescription).